Pulmonx (LUNG) Notes Payables (2019 - 2025)

Pulmonx (LUNG) has reported Notes Payables for 7 consecutive years, with $106000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Notes Payables fell 96.66% year-over-year to $106000.0 in Q4 2025; TTM through Dec 2025 was $106000.0, a 96.66% decrease from a year earlier, with the FY2025 full-year figure at $106000.0, down 96.66% from the prior year.
• Notes Payables was $106000.0 for Q4 2025 at Pulmonx, up from $105000.0 in the prior quarter.
• Over five years, Notes Payables peaked at $17.3 million in Q4 2021 and troughed at $90000.0 in Q4 2022.
• A 5-year average of $4.5 million and a median of $1.5 million in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables slumped 99.48% in 2022 and surged 5648.35% in 2024, its largest moves.
• Over 5 years, Notes Payables stood at $17.3 million in 2021, then tumbled by 99.48% to $90000.0 in 2022, then surged by 2294.44% to $2.2 million in 2023, then jumped by 47.38% to $3.2 million in 2024, then sank by 96.66% to $106000.0 in 2025.
• The last three Notes Payables figures came in at $106000.0 (Q4 2025), $105000.0 (Q3 2025), and $104000.0 (Q2 2025), per Business Quant data.